Jeena Sikho Lifecare Fair Value
Jeena Sikho Lifecare (JSLL) average fair value is ₹113.08 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹650.6 (-82.62%), fair value range ₹62.57–₹230.4. For live price and a broader fundamental view, visit Jeena Sikho Lifecare share price today.
Fair Value Analysis Export
JSLL Fair Value vs Current Price — Valuation Summary
JSLL average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. See JSLL P/B ratio history to compare market price against book value per share.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
JSLL Fair Value Analysis — Data Sources & Coverage
Jeena Sikho Lifecare financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine Jeena Sikho Lifecare quarterly financials for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
JSLL vs Healthcare Sector Peers — P/E, P/B & Market Cap
Jeena Sikho Lifecare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
| KRM Ayurveda | KRMAYURVED | - | 4.07 | ₹508 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.